176 related articles for article (PubMed ID: 26520391)
1. Receptome: Interactions between three pain-related receptors or the "Triumvirate" of cannabinoid, opioid and TRPV1 receptors.
Zádor F; Wollemann M
Pharmacol Res; 2015 Dec; 102():254-63. PubMed ID: 26520391
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptors in osteoporosis and osteoporotic pain: a narrative update of review.
Wang J; Lu HX; Wang J
J Pharm Pharmacol; 2019 Oct; 71(10):1469-1474. PubMed ID: 31294469
[TBL] [Abstract][Full Text] [Related]
3. Effects of coadministration of low dose cannabinoid type 2 receptor agonist and morphine on vanilloid receptor 1 expression in a rat model of cancer pain.
Zhang M; Chi M; Zou H; Tian S; Zhang Z; Wang G
Mol Med Rep; 2017 Nov; 16(5):7025-7031. PubMed ID: 28901432
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
5. TRPV1 and MOR working in tandem: implications for pain and opioids use.
Abdullah N; Altier C
Neuropsychopharmacology; 2020 Jan; 45(1):225-226. PubMed ID: 31501526
[No Abstract] [Full Text] [Related]
6. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.
Chen SR; Prunean A; Pan HM; Welker KL; Pan HL
Neuroscience; 2007 Mar; 145(2):676-85. PubMed ID: 17239544
[TBL] [Abstract][Full Text] [Related]
7. Diverse TRPV1 responses to cannabinoids.
Starkus J; Jansen C; Shimoda LMN; Stokes AJ; Small-Howard AL; Turner H
Channels (Austin); 2019 Dec; 13(1):172-191. PubMed ID: 31096838
[TBL] [Abstract][Full Text] [Related]
8. Mother root of Aconitum carmichaelii Debeaux exerts antinociceptive effect in Complet Freund's Adjuvant-induced mice: roles of dynorpin/kappa-opioid system and transient receptor potential vanilloid type-1 ion channel.
Wang C; Sun D; Liu C; Zhu C; Jing X; Chen S; Liu C; Zhi K; Xu T; Wang H; Liu J; Xu Y; Liu Z; Lin N
J Transl Med; 2015 Aug; 13():284. PubMed ID: 26320055
[TBL] [Abstract][Full Text] [Related]
9. TRPV1-FAAH-COX: The Couples Game in Pain Treatment.
Aiello F; Carullo G; Badolato M; Brizzi A
ChemMedChem; 2016 Aug; 11(16):1686-94. PubMed ID: 27240888
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies.
Nadal X; La Porta C; Andreea Bura S; Maldonado R
Eur J Pharmacol; 2013 Sep; 716(1-3):142-57. PubMed ID: 23523475
[TBL] [Abstract][Full Text] [Related]
11. Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain.
Lee H; Ahn S; Ann J; Ha H; Yoo YD; Kim YH; Hwang JY; Hur KH; Jang CG; Pearce LV; Esch TE; Lewin NE; Blumberg PM; Lee J
Eur J Med Chem; 2019 Nov; 182():111634. PubMed ID: 31472474
[TBL] [Abstract][Full Text] [Related]
12. Cellular mechanisms underlying the interaction between cannabinoid and opioid system.
Parolaro D; Rubino T; Viganò D; Massi P; Guidali C; Realini N
Curr Drug Targets; 2010 Apr; 11(4):393-405. PubMed ID: 20017730
[TBL] [Abstract][Full Text] [Related]
13. Opioids and cannabinoids interactions: involvement in pain management.
Desroches J; Beaulieu P
Curr Drug Targets; 2010 Apr; 11(4):462-73. PubMed ID: 20017728
[TBL] [Abstract][Full Text] [Related]
14. TRPV1 signaling: mechanistic understanding and therapeutic potential.
Xia R; Samad TA; Btesh J; Jiang LH; Kays I; Stjernborg L; Dekker N
Curr Top Med Chem; 2011; 11(17):2180-91. PubMed ID: 21671876
[TBL] [Abstract][Full Text] [Related]
15. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the cannabinoid and opioid systems in the modulation of nociception.
Welch SP
Int Rev Psychiatry; 2009 Apr; 21(2):143-51. PubMed ID: 19367508
[TBL] [Abstract][Full Text] [Related]
17. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
19. Hot receptors in the brain.
Steenland HW; Ko SW; Wu LJ; Zhuo M
Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
[TBL] [Abstract][Full Text] [Related]
20. Addiction and pain: cannabinoid and opioid interactions.
Tucci S
Curr Drug Targets; 2010 Apr; 11(4):392. PubMed ID: 20196743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
